Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinryze for acute management of moderate to severe traumatic brain injury
NL-OMON52831Phase 2Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in traumatic brain injury (TBI) comparing Cinryze with Placebo (2 arms). Primary endpoints: Therapy Intensity Level mean over 4 days, Extended Glasgow Outcome Scale at 6 months and 1 more. Started Apr 2021; status: recruiting.
02
Drugs
c1-esterase inhibitor
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NL-OMON52831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52831.